Tevogen Bio Reports Series A-1 Preferred Stock Investment at $10 Conversion Price The shares of Series A-1 Preferred Stock will be issued in the first quarter and will be convertible at a conversion price of $10.00, as opposed to the $4.

Tevogen Bio Announces Series A-1 Preferred Stock Investment The shares of Series A-1 Preferred Stock will be issued in the first quarter and will be convertible at a conversion price of $10.00, as opposed to the $4.